Improvement of radioimmunotherapy using pretargeting

Improvement of radioimmunotherapy using pretargeting

During the past two decades, considerable research has been devoted to radionuclide therapy using radiolabelled monoclonal antibodies and receptor binding agents. Conventional Radioimmunotherapy (RIT) is now an established and important tool in the treatment of hematologic malignancies such as Non-H...

Full description

Bibliographic Details
Main Authors: Eric eFrampas, Caroline eRousseau, Caroline eBodet-Milin, Jacques eBarbet, Jean-Francois eChatal, Françoise eKraeber-Bodéré
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-06-01
Series:Frontiers in Oncology
Subjects:
Radioimmunotherapy
pretargeting
bispecific antibody
CEA
avidin-biotin
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00159/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00159/full

Similar Items